---
title: Lacamas Laboratories Inc. vs 重庆兴泰濠制药有限公司 (Sintaho)
slug_a: lacamaslabs
slug_b: sintaho
site: cdmo
review_signal_gate: closed
canonical_path: /compare/lacamaslabs/sintaho
generated_by: BioBM Editorial AI
---

# Lacamas Laboratories Inc. vs 重庆兴泰濠制药有限公司 (Sintaho)

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Lacamas Laboratories Inc. (lacamaslabs) is listed for cdmo. Large-scale contract manufacturer of pharmaceutical intermediates and fine chemicals with over 32,000 gallons of reactor capability, specializing in process development, scale-up, and hazardous chemistry handling.

Services: 3. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (3).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

重庆兴泰濠制药有限公司 (Sintaho) (sintaho) is listed for cdmo. China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.

Services: 4. Modalities: 2. Indications: 0. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.